364 related articles for article (PubMed ID: 36110528)
1. Comprehensive bioinformatics analysis to identify a novel cuproptosis-related prognostic signature and its ceRNA regulatory axis and candidate traditional Chinese medicine active ingredients in lung adenocarcinoma.
Wang S; Xing N; Meng X; Xiang L; Zhang Y
Front Pharmacol; 2022; 13():971867. PubMed ID: 36110528
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of a cuproptosis-related ceRNA network implicates a potential endocrine therapy resistance mechanism in ER-positive breast cancer.
Zhang D; Lu W; Zhuo Z; Wang Y; Zhang W; Zhang M
BMC Med Genomics; 2023 May; 16(1):96. PubMed ID: 37143115
[TBL] [Abstract][Full Text] [Related]
3. Identification and Validation of Cuproptosis-Related Prognostic Signature and Associated Regulatory Axis in Uterine Corpus Endometrial Carcinoma.
Chen Y
Front Genet; 2022; 13():912037. PubMed ID: 35937995
[No Abstract] [Full Text] [Related]
4. Identification and validation of a novel cuproptosis-related signature as a prognostic model for lung adenocarcinoma.
Chen Y; Tang L; Huang W; Zhang Y; Abisola FH; Li L
Front Endocrinol (Lausanne); 2022; 13():963220. PubMed ID: 36353226
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of cuproptosis-related prognostic gene signature and tumor immune microenvironment in HCC.
Qin H; Sheng W; Zhang G; Yang Q; Yao S; Yue Y; Zhang P; Zhu Y; Wang Q; Chen Y; Zeng H; Weng J; Yu F; Yang J
Front Genet; 2023; 14():1094793. PubMed ID: 36891150
[No Abstract] [Full Text] [Related]
6. A novel cuproptosis-related prognostic lncRNA signature and lncRNA MIR31HG/miR-193a-3p/TNFRSF21 regulatory axis in lung adenocarcinoma.
Mo X; Hu D; Yang P; Li Y; Bashir S; Nai A; Ma F; Jia G; Xu M
Front Oncol; 2022; 12():927706. PubMed ID: 35936736
[TBL] [Abstract][Full Text] [Related]
7. Cuproptosis-Related Genes MTF1 and LIPT1 as Novel Prognostic Biomarker in Acute Myeloid Leukemia.
Li Y; Kan X
Biochem Genet; 2024 Apr; 62(2):1136-1159. PubMed ID: 37561332
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value and immunological function of cuproptosis-related genes in lung adenocarcinoma.
Zhang L; Wang S; Wang L
Heliyon; 2024 May; 10(9):e30446. PubMed ID: 38694039
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of cuproptosis-related lncRNAs associated with pancreatic cancer immune microenvironment based on single-cell.
Sun Y; Yao L; Man C; Gao Z; He R; Fan Y
Front Immunol; 2023; 14():1220760. PubMed ID: 37822927
[TBL] [Abstract][Full Text] [Related]
10. Cuproptosis Related Gene DLD Associated with Poor Prognosis and Malignant Biological Characteristics in Lung Adenocarcinoma.
Li X; Rui J; Yang Z; Shang-Guan F; Shi H; Wang D; Sun J
Curr Cancer Drug Targets; 2024 Jan; ():. PubMed ID: 38310466
[TBL] [Abstract][Full Text] [Related]
11. [Construction of Lung Adenocarcinoma Prognosis Model and Drug Sensitivity Analysis Based on Cuproptosis Related Genes].
Sun J; Zhang H; Liu H; Dong Y; Wang P
Zhongguo Fei Ai Za Zhi; 2023 Aug; 26(8):591-604. PubMed ID: 37752539
[TBL] [Abstract][Full Text] [Related]
12. Integrated analysis identifies cuproptosis-related gene DLAT and its competing endogenous RNAs network to predict the prognosis of pancreatic adenocarcinoma patients.
Zhou C; Jin L; Yu J; Gao Z
Medicine (Baltimore); 2024 Mar; 103(9):e37322. PubMed ID: 38428843
[TBL] [Abstract][Full Text] [Related]
13. Role of cuproptosis-related gene in lung adenocarcinoma.
Liu Y; Lin W; Yang Y; Shao J; Zhao H; Wang G; Shen A
Front Oncol; 2022; 12():1080985. PubMed ID: 36620594
[TBL] [Abstract][Full Text] [Related]
14. Identification of cuproptosis-related subtypes in lung adenocarcinoma and its potential significance.
Pan S; Song C; Meng H; Li N; Li D; Hao B; Lu Z; Geng Q
Front Pharmacol; 2022; 13():934722. PubMed ID: 36263125
[TBL] [Abstract][Full Text] [Related]
15. Database Mining Detected a Cuproptosis-Related Prognostic Signature and a Related Regulatory Axis in Breast Cancer.
Jiang B; Zhu H; Feng W; Wan Z; Qi X; He R; Xie L; Li Y
Dis Markers; 2022; 2022():9004830. PubMed ID: 36312586
[TBL] [Abstract][Full Text] [Related]
16. A cuproptosis-related gene signature and associated regulatory axis in stomach adenocarcinoma based on bioinformatics analysis.
Ding D; Wang D; Qin Y
Medicine (Baltimore); 2023 Jul; 102(30):e34230. PubMed ID: 37505170
[TBL] [Abstract][Full Text] [Related]
17. Validation of a Novel Cuproptosis-Related Prognostic Gene Marker and Differential Expression Associated with Lung Adenocarcinoma.
Liu T; Wei J
Curr Issues Mol Biol; 2023 Oct; 45(10):8502-8518. PubMed ID: 37886979
[TBL] [Abstract][Full Text] [Related]
18. Prediction of risk and clinical outcome of cuproptosis in lung squamous carcinoma.
Zhang Y; Zhou J; Li H; Liu Y; Li J
BMC Pulm Med; 2023 Jun; 23(1):205. PubMed ID: 37308925
[TBL] [Abstract][Full Text] [Related]
19. Identification of GLS as a cuproptosis-related diagnosis gene in acute myocardial infarction.
Liu Z; Wang L; Xing Q; Liu X; Hu Y; Li W; Yan Q; Liu R; Huang N
Front Cardiovasc Med; 2022; 9():1016081. PubMed ID: 36440046
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk of cuproptosis-related prognostic signature and competing endogenous RNAs regulation in hepatocellular carcinoma.
Zhu J; Wang J; Liu H; Lei T; Yang J; Lan S; Jian H; Fang H; Zhang Y; Ren K; Zhong F
Aging (Albany NY); 2023 Dec; 15(23):13901-13919. PubMed ID: 38078880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
